212 related articles for article (PubMed ID: 37371499)
1. Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice.
Brandão SR; Reis-Mendes A; Duarte-Araújo M; Neuparth MJ; Rocha H; Carvalho F; Ferreira R; Costa VM
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371499
[TBL] [Abstract][Full Text] [Related]
2. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
[TBL] [Abstract][Full Text] [Related]
3. The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases.
Brandão SR; Reis-Mendes A; Neuparth MJ; Carvalho F; Ferreira R; Costa VM
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004479
[TBL] [Abstract][Full Text] [Related]
4. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
5. Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cells.
Reis-Mendes A; Carvalho F; Remião F; Sousa E; de Lourdes Bastos M; Costa VM
Arch Toxicol; 2023 Jan; 97(1):201-216. PubMed ID: 36216988
[TBL] [Abstract][Full Text] [Related]
6. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Brito V; Morás AM; Henriques JAP; Saffi J
Toxicol In Vitro; 2018 Oct; 52():203-213. PubMed ID: 29913208
[TBL] [Abstract][Full Text] [Related]
7. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
10. PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis.
Zhou M; Sun X; Wang C; Wang F; Fang C; Hu Z
Sci Rep; 2022 Jul; 12(1):11684. PubMed ID: 35804014
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
[TBL] [Abstract][Full Text] [Related]
13. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
[TBL] [Abstract][Full Text] [Related]
14. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
15. PCSK6 attenuates cardiac dysfunction in doxorubicin-induced cardiotoxicity by regulating autophagy.
Li C; Guo Z; Liu F; An P; Wang M; Yang D; Tang Q
Free Radic Biol Med; 2023 Jul; 203():114-128. PubMed ID: 37061139
[TBL] [Abstract][Full Text] [Related]
16. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway.
Zhang S; Wei X; Zhang H; Wu Y; Jing J; Huang R; Zhou T; Hu J; Wu Y; Li Y; You Z
Biomed Pharmacother; 2023 Jun; 162():114691. PubMed ID: 37060659
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
[TBL] [Abstract][Full Text] [Related]
19. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]